WVE Q4 2020 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+293.3% YoY

Gross Profit

-$21M-218.2% margin

Operating Income

-$30M-321.1% margin

Net Income

-$29M-305.0% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

+173.6%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$279M

Total Liabilities

$189M

Stockholders' Equity

$91M

Cash & Equivalents

$184M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$2M	+293.3%
Gross Profit	-$21M	-$47M	+55.9%
Operating Income	-$30M	-$61M	+49.9%
Net Income	-$29M	-$57M	+49.3%